All Posts

The FDA has approved centanafadine (Simtriyo), a first-in-class medication for attention-deficit/hyperactivity disorder (ADHD). Learn about its unique triple reuptake inhibition mechanism, what clinical research has demonstrated, and important considerations for patients exploring ADHD treatment options.

Introducing Encompass Health & Psychiatry, offering personalized virtual psychiatric care for adults throughout Texas. Discover our evidence-based, whole-person approach to mental health and wellness.